ERBB2 and breast carcinoma: In multivariable analysis, only a T cell-related metagene was found to be significantly correlated with disease-free survival (P = 0.01) when considering a mixed population of 1,263 patients with breast cancer; consequently, this was the metagene carried forward for further analysis in ER and HER2 status-specific populations.